These results are consistent with a model in which the presence of the rs636317-T AD risk-increasing allele leads to disruption of CTCF binding, decreased chromatin accessibility at this site, altered chromatin looping and activity in the locus, and increased expression of MS4A6A in microglia. This evidence concerns the gene MS4A6A and Alzheimer disease.